Staff Members - Benha University
Metabolic syndrome in androgenetic alopecia patients; Is serum regulated on activation, normal T-cell expressed and secreted the missing link?
• 2020
Publication Information
Authors
Amany Ibrahim Mustafa MD1 | Walid Abd Ellatif Abel Halim MD2 |
Fawzy Eman PhD3 | El-Habbak Doaa MD1
Keywords
Not Available
Journal
Not Available
Publisher
Not Available
Volume
Not Available
Issue
Not Available
Pages
Not Available
publication.type
Local
Paper Link
Not Available
Supplementary Materials
Not Available
Abstract
Background: Androgenetic alopecia (AGA) is the most common cause of hair loss
affecting both men and women. There are many conflicting results about the relationship between AGA and metabolic syndrome, (MetS) and the pathogenesis of the
metabolic disorders in AGA patients is not completely elucidated.
Aims: Evaluation of the prevalence of MetS and the possible role of RANTES in
pathogenesis of the MS among AGA patients.
Methods: A total of 160 subjects were enrolled in this work; included 100 patients
clinically diagnosed with AGA and 60 apparently healthy control subjects. They were
evaluated for MS components according to National Cholesterol Education Program
(NCEP) adult treatment panel 3 (ATP3) and measurement of serum RANTES level
using ELISA kits.
Results: Metabolic syndrome was present in 30.0% of AGA patients and in 10.0%
of the control group (P = .038), Studied AGA patients showed significantly higher
serum RANTES when compared to control group (P value < .001). Moreover, serum
RANTES levels were significantly positively correlated with BMI, FBG, TC, and LDL-c
levels in AGA patients with MetS.
Conclusion: Metabolic syndrome components were prevalent among AGA patients.
Serum RANTES level was significantly higher in all AGA patients and specifically in
those with MS as it was significantly positively correlated with some MetS components which reflects its possible role in pathogenesis of MetS in AGA patients.
affecting both men and women. There are many conflicting results about the relationship between AGA and metabolic syndrome, (MetS) and the pathogenesis of the
metabolic disorders in AGA patients is not completely elucidated.
Aims: Evaluation of the prevalence of MetS and the possible role of RANTES in
pathogenesis of the MS among AGA patients.
Methods: A total of 160 subjects were enrolled in this work; included 100 patients
clinically diagnosed with AGA and 60 apparently healthy control subjects. They were
evaluated for MS components according to National Cholesterol Education Program
(NCEP) adult treatment panel 3 (ATP3) and measurement of serum RANTES level
using ELISA kits.
Results: Metabolic syndrome was present in 30.0% of AGA patients and in 10.0%
of the control group (P = .038), Studied AGA patients showed significantly higher
serum RANTES when compared to control group (P value < .001). Moreover, serum
RANTES levels were significantly positively correlated with BMI, FBG, TC, and LDL-c
levels in AGA patients with MetS.
Conclusion: Metabolic syndrome components were prevalent among AGA patients.
Serum RANTES level was significantly higher in all AGA patients and specifically in
those with MS as it was significantly positively correlated with some MetS components which reflects its possible role in pathogenesis of MetS in AGA patients.